A retrospective validation of CanAssist Breast in European early-stage breast cancer patient cohort-Reference-Cited by-同舟云学术

A retrospective validation of CanAssist Breast in European early-stage breast cancer patient cohort

Published:2022-06 Issue: Volume:63 Page:1-8
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Gunda Aparna,Basavaraj Chetana,Serkad V Chandra Prakash,Adinarayan Manjula,Kolli Ramu,Siraganahalli Eshwaraiah Mallikarjuna,Saura Cristina,Ruiz Fiorella^ORCID,Gomez Patricia,Peg Vicente,Jimenez Jose^ORCID,Sprung Susanne,Fiegl Heidi,Brunner Christine,Egle Daniel,Bhattacharyya GS,Bakre Manjiri M^ORCID

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference31 articles.

1. Multigene testing in breast cancer: what have we learned from the 21-gene recurrence score assay?;Turashvili;Breast J,2020

2. Expected monetary impact of Oncotype DX score-concordant systemic breast cancer therapy based on the TAILORx trial;Mariotto;J Natl Cancer Inst,2020

3. Cost effectiveness of gene expression profile testing in community practice;Chandler;J Clin Oncol,2018

4. Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry;Stemmer;NPJ Breast Cancer,2017

5. Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry;Stemmer;NPJ Breast Cancer,2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk Stratification of Early Breast Cancer (HR +/HER 2–) by CanAssist Breast and Its Corelation with Other Online Prognostic Tools: Experience from a Single Center;Indian Journal of Medical and Paediatric Oncology;2023-08-17

2. Consensus guidelines for the management of HR-positive HER2/neu negative early breast cancer in India, SAARC region and other LMIC by DELPHI survey method;BMC Cancer;2023-07-31

3. Cancer Diagnosis Using Artificial Intelligence (AI) and Internet of Things (IoT);Advances in Healthcare Information Systems and Administration;2023-06-12

4. The usefulness of CanAssist Breast over Ki67 in breast cancer recurrence risk assessment;Cancer Medicine;2023-05-28

5. Ten-year distant-recurrence risk prediction in breast cancer by CanAssist Breast (CAB) in Dutch sub-cohort of the randomized TEAM trial;Breast Cancer Research;2023-04-14